Abstract: A novel transcription factor, belong to the E2f gene family, is disclosed. This is called E2F-4. It interacts with DP-1 and can be regulated by p107.
Type:
Grant
Filed:
May 14, 1997
Date of Patent:
April 4, 2000
Assignee:
Prolifix Limited
Inventors:
Rene Bernards, Roderick L. Beijersbergen
Abstract: Transcription units encoded in the minimal DGS/VCFS critical region, primer pairs effective for amplifying said transcripts in a genomic DNA sample for the preparation of probes for detecting genetic deletions/mutations in the minimal DGS/VCFS critical region, and kits containing the probes are disclosed. One or more of said transcription units is implicated for the abnormalities associated with DGS/VCFS.
Type:
Grant
Filed:
December 27, 1996
Date of Patent:
August 10, 1999
Assignees:
Children's Hospital of Philadelphia, University of Oklahoma
Inventors:
Weilong Gong, Beverly S. Emanuel, Marcia L. Budarf, Bruce Roe
Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
Abstract: Environmental formaldehyde can be detected and remediated in a biological system that incorporates a bacterial cell containing suitable genetic sequences encoding a formaldehyde-inducible regulatory system. The system includes a transcriptional promoter that can be specifically induced in the presence of formaldehyde to transcribe an operably linked gene.
Type:
Grant
Filed:
February 28, 1996
Date of Patent:
May 5, 1998
Assignee:
Wisconsin Alumni Research Foundation
Inventors:
Timothy J. Donohue, Robert D. Barber, Vern Witthuhn